酸盐激酶的功能与红细胞特性和状细胞疾病的临床表现相关
M J M Traets1, J F Bos1, S van der Veen2
1Department of Central Diagnostic Laboratory-Research, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
American journal of hematology
|February 21, 2025
概括
在状细胞病 (SCD) 红细胞 (RBC) 中,受损的酸盐激酶 (PK) 功能与疾病的严重程度有关. 较低的PK活性和稳定性与较差的红细胞功能和增加的临床并发症相关,表明PK激活治疗的潜力.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
背景情况:
- 酸盐激酶 (PK) 对于糖解和ATP产生至关重要.
- 减少红细胞 (RBC) PK活性和热稳定性与状细胞疾病 (SCD) 病理生理学有关.
- PK/hexokinase (HK) 比率和PK的热稳定性是PK功能的关键指标.
研究的目的:
- 为了研究 PK 功能受损与状红细胞特性之间的关联.
- 确定减少的PK功能是否与SCD相关的临床表现相关.
- 探索PK激活治疗SCD的潜力.
主要方法:
- 研究了97名患有SCD (HbSS和HbS/β0血症) 的非输血患者.
- 评估了PK的热稳定性和PK/HK的比率.
- 与红细胞特征相关的PK功能参数 (网细胞计数,HbF,状点,氧 afinity,红细胞可变,粘附) 和使用多变量波桑回归的临床并发症.
主要成果:
- 关联的PK热稳定性与网细胞计数,HbF,状点,氧 afinity,和RBC粘附于拉米尼.
- 低的PK/HK比率与PK的热稳定性降低,红细胞变形性降低和2,3-二糖酸盐的升高有关.
- 减少PK热稳定性和PK/HK比率独立地与较高的SCD临床并发症发生率相关.
结论:
- 损坏的PK功能与损害的状红细胞特性有关.
- 减少PK活性和稳定性是SCD临床表现的重要风险因素.
- 这些发现支持在SCD管理中准PK的治疗潜力.
相关概念视频
Disorders of Erythrocytes
840
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
840
Multiple Allele Traits
33.9K
The Concept of Multiple Allelism
33.9K
Pyruvate Oxidation
158.0K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
158.0K
Factors Affecting Erythropoiesis
3.0K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.0K
Inborn Errors of Metabolism
123
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
123
Fates of Pyruvate
8.3K
Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
8.3K


